Literature DB >> 7806028

Why can high insulin levels indicate a risk for coronary heart disease?

A Fontbonne1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7806028     DOI: 10.1007/bf00400954

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  16 in total

Review 1.  Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis.

Authors:  C N Hales; D J Barker
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

2.  Insulin. A sex hormone for cardiovascular risk?

Authors:  A Fontbonne
Journal:  Circulation       Date:  1991-09       Impact factor: 29.690

3.  Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland.

Authors:  K Pyöräla
Journal:  Diabetes Care       Date:  1979 Mar-Apr       Impact factor: 19.112

Review 4.  Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

Authors:  R A DeFronzo
Journal:  Diabetes       Date:  1988-06       Impact factor: 9.461

5.  Body fat distribution and coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes mellitus: the Paris Prospective Study, 15-year follow-up.

Authors:  A Fontbonne; N Thibult; E Eschwège; P Ducimetière
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

Review 6.  Plasma triglyceride and coronary heart disease.

Authors:  M A Austin
Journal:  Arterioscler Thromb       Date:  1991 Jan-Feb

7.  Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up.

Authors:  A Fontbonne; M A Charles; N Thibult; J L Richard; J R Claude; J M Warnet; G E Rosselin; E Eschwège
Journal:  Diabetologia       Date:  1991-05       Impact factor: 10.122

8.  Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations.

Authors:  T A Welborn; K Wearne
Journal:  Diabetes Care       Date:  1979 Mar-Apr       Impact factor: 19.112

9.  Hyperinsulinaemia is not a major coronary risk factor in elderly men. The study of men born in 1913.

Authors:  L Welin; H Eriksson; B Larsson; L O Ohlson; K Svärdsudd; G Tibblin
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

10.  Insulin treatment, endogenous insulin concentration, and ECG abnormalities in diabetic Pima Indians. Cross-sectional and prospective analyses.

Authors:  Q Z Liu; W C Knowler; R G Nelson; M F Saad; M A Charles; I M Liebow; P H Bennett; D J Pettitt
Journal:  Diabetes       Date:  1992-09       Impact factor: 9.461

View more
  6 in total

1.  Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore.

Authors:  K Hughes; T C Aw; P Kuperan; M Choo
Journal:  J Epidemiol Community Health       Date:  1997-08       Impact factor: 3.710

2.  Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography.

Authors:  G Paternostro; P G Camici; A A Lammerstma; N Marinho; R R Baliga; J S Kooner; G K Radda; E Ferrannini
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 3.  Insulin deficiency and insulin resistance in the pathogenesis of NIDDM: is a divorce possible?

Authors:  E Cerasi
Journal:  Diabetologia       Date:  1995-08       Impact factor: 10.122

Review 4.  The insulin resistance syndrome: the controversy is dead, long live the controversy!

Authors:  M P Stern
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

5.  Prevalence of metabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study.

Authors:  Cihangir Erem; Arif Hacihasanoglu; Orhan Deger; Murat Topbaş; Ilgin Hosver; Halil Onder Ersoz; Gamze Can
Journal:  Endocrine       Date:  2008-03-13       Impact factor: 3.633

6.  The effects of high dose pravastatin and low dose pravastatin and ezetimibe combination therapy on lipid, glucose metabolism and inflammation.

Authors:  Necati Dagli; Mustafa Yavuzkir; Ilgin Karaca
Journal:  Inflammation       Date:  2007-08-09       Impact factor: 4.092

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.